Telangiectasia, Hereditary Hemorrhagic
"Telangiectasia, Hereditary Hemorrhagic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An autosomal dominant vascular anomaly characterized by telangiectases of the skin and mucous membranes and by recurrent gastrointestinal bleeding. This disorder is caused by mutations of a gene (on chromosome 9q3) which encodes endoglin, a membrane glycoprotein that binds TRANSFORMING GROWTH FACTOR BETA.
MeSH Number(s)
C14.907.454.900
C14.907.823.780
C15.378.463.515.900
C16.131.240.850.968
Concept/Terms
Telangiectasia, Hereditary Hemorrhagic- Telangiectasia, Hereditary Hemorrhagic
- Hemorrhagic Telangiectasia, Hereditary
- Hereditary Hemorrhagic Telangiectasia
- Telangiectasia, Hereditary Hemorrhagic, Type 1
- Osler-Weber-Rendu Syndrome
- Osler Weber Rendu Syndrome
- Telangiectasia, Hereditary Hemorrhagic, of Rendu, Osler, and Weber
- Osler-Rendu Disease
- Osler Rendu Disease
- Osler-Rendu-Weber Disease
- Osler Rendu Weber Disease
Below are MeSH descriptors whose meaning is more general than "Telangiectasia, Hereditary Hemorrhagic".
Below are MeSH descriptors whose meaning is more specific than "Telangiectasia, Hereditary Hemorrhagic".
This graph shows the total number of publications written about "Telangiectasia, Hereditary Hemorrhagic" by people in Harvard Catalyst Profiles by year, and whether "Telangiectasia, Hereditary Hemorrhagic" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 3 | 0 | 3 |
| 1995 | 3 | 0 | 3 |
| 1996 | 2 | 0 | 2 |
| 1997 | 2 | 0 | 2 |
| 1998 | 1 | 0 | 1 |
| 1999 | 1 | 0 | 1 |
| 2000 | 2 | 0 | 2 |
| 2001 | 0 | 2 | 2 |
| 2002 | 1 | 1 | 2 |
| 2003 | 1 | 0 | 1 |
| 2005 | 1 | 0 | 1 |
| 2006 | 3 | 1 | 4 |
| 2007 | 4 | 0 | 4 |
| 2009 | 2 | 0 | 2 |
| 2010 | 2 | 0 | 2 |
| 2012 | 3 | 1 | 4 |
| 2014 | 2 | 0 | 2 |
| 2015 | 1 | 1 | 2 |
| 2016 | 1 | 0 | 1 |
| 2017 | 3 | 0 | 3 |
| 2018 | 8 | 0 | 8 |
| 2019 | 5 | 0 | 5 |
| 2020 | 3 | 1 | 4 |
| 2021 | 10 | 0 | 10 |
| 2022 | 9 | 0 | 9 |
| 2023 | 5 | 0 | 5 |
Below are the most recent publications written about "Telangiectasia, Hereditary Hemorrhagic" by people in Profiles.
-
Executive summary of the 14th HHT international scientific conference. Angiogenesis. 2023 08; 26(Suppl 1):27-37.
-
Risk factors and clinical features associated with basal ganglia manganese deposition in patients with hereditary hemorrhagic telangiectasia. Clin Imaging. 2023 Sep; 101:183-189.
-
Antithrombotic therapy for atrial fibrillation in hereditary hemorrhagic telangiectasia. J Thromb Thrombolysis. 2023 Aug; 56(2):355-359.
-
Anticoagulation and antiplatelet therapy in hereditary hemorrhagic telangiectasia: A scoping review. Thromb Res. 2023 06; 226:150-155.
-
The challenges of pregnancy with hereditary haemorrhagic telangiectasia. BJOG. 2023 05; 130(6):689-690.
-
Safety, tolerability, and effectiveness of anticoagulation and antiplatelet therapy in hereditary hemorrhagic telangiectasia. J Thromb Haemost. 2023 01; 21(1):26-36.
-
Polymicrobial brain abscess as the initial presentation of hereditary hemorrhagic telangiectasia in a teenage girl. Pediatr Pulmonol. 2022 11; 57(11):2877-2879.
-
An additional patient with SMAD4-Juvenile Polyposis-Hereditary hemorrhagic telangiectasia and connective tissue abnormalities: SMAD4 loss-of-function and gain-of-function pathogenic variants result in contrasting phenotypes. Am J Med Genet A. 2022 Oct; 188(10):3084-3088.
-
Doxycycline for bleeding in hereditary hemorrhagic telangiectasia: When low-hanging fruit meets inconvenient data. J Thromb Haemost. 2022 05; 20(5):1067-1069.
-
Diagnosis and Management of Cancer Risk in the Gastrointestinal Hamartomatous Polyposis Syndromes: Recommendations From the US Multi-Society Task Force on Colorectal Cancer. Am J Gastroenterol. 2022 06 01; 117(6):846-864.